Korro Bio, Inc.KRRONASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank13
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-1281.07%
↓ 96% vs avg
Percentile
P13
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-652.18%
Historical baseline
PeriodValueYoY Change
TTM-1281.07%+67.1%
2024-3890.14%-
20230.00%-
20220.00%+100.0%
2021-569.14%-745.5%
2020-67.32%-8.7%
2019-61.95%-
20180.00%-
20170.00%-